Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Fusion Antibodies Plc (LSE:FAB) Declines as Antibody Services Demand Remains Under Review

Fusion Antibodies Plc (LSE:FAB) was quoted at 10.56 GBX on 26 August 2026, a decline of 6.18% on the session. The movement placed the company among the softer performers across the London market during the day's trading.

Ankur Sharma | 26 August 2026

Oxford Nanopore Technologies plc (LSE:ONT) Retreats as Sequencing Adoption Trends Stay in Focus

Oxford Nanopore Technologies plc (LSE:ONT) was quoted at 178.70 GBX on 26 August 2026, a decline of 2.35% on the session. The movement placed the company among the softer performers across the London market during the day's trading.

Ankur Sharma | 26 August 2026

ProBiotix Health Holds Near 10.5p After 16% Rally: Is the Profit Turnaround Gaining Traction?

ProBiotix Health Plc (LSE:PBX) remained on investors’ radar after a single trade lifted the shares by approximately 16.02% during the previous session.

Ankur Sharma | 26 August 2026

Sareum Shares Extend Their Rally: Is the SDC-1801 Programme Entering a New Phase?

Sareum Holdings Plc (LSE:SAR), the AIM-quoted biotechnology company developing next-generation kinase inhibitors, extended its recent rally on 26 August 2026. After closing at 37p in the previous session, the shares traded at approximately 38p, representing a further gain of around 2.70%.

Ankur Sharma | 26 August 2026

Diaceutics Shares Jump: Could Precision Medicine Drive the Next Phase of Growth?

The immediate catalyst on the day was modest in isolation: a 2.87% advance to 143.5p, valuing the company at about £118m. That places Diaceutics firmly in small-cap territory, whereLiquidityis thin and daily moves can be exaggerated by relatively small volumes. There was no fresh …

Divya Sood | 26 August 2026

Coiled Therapeutics Stock Falls 5%: Why LSE:COIL Shares Are in Focus Ahead of AO-252 Clinical Data

Coiled Therapeutics Plc has become an increasingly watched small-cap healthcare stock because itsInvestmentcase is now centred around clinical development rather than established commercial revenues.

Ankur Sharma | 26 August 2026

LSE:MPAL Share Price Under Pressure After Rapid Rally: AI Health Platform, Pharmacy Growth and GLP-1 Demand in Focus

MedPal AI PLC has become one of the more closely watched smaller UK healthcare technology shares because it sits at the intersection of several powerfulInvestmentthemes: artificial intelligence, digital healthcare, personalised wellness, online pharmacy services and the rapidly expanding weight-management market.

Ankur Sharma | 26 August 2026

Ondine Biomedical Shares Slide 4.08%: Steriwave Growth, U.S. Phase 3 Results and NHS Adoption in Focus

Ondine Biomedical has become one of the more closely watched small-cap healthcare stocks because its technology addresses several major healthcare challenges simultaneously.

Ankur Sharma | 26 August 2026

AOTI, Inc. Shares Gain 2.52% as Medicare Opportunity and Improving US Momentum Lift Investor Optimism

AOTI shares rose by 2.52% as the market continued to assess the significance of the company’s recent operating update and the proposed Medicare coverage pathway for topical oxygen therapy. The update indicated resilient underlying demand, a recovery in the Veterans AdministrationBusinessand improving working-capital conditions.

Ankur Sharma | 26 August 2026

Diaceutics Plc Shares Rise 2.87% as Recurring Revenue Momentum and Precision-Medicine Expansion Strengthen Investor Optimism

The share-price increase appears to reflect continued investor appreciation of Diaceutics’ improving commercial and financial profile. Its latest trading update reported strong expansion in annual recurring revenue, underlying sales growth and a substantial contracted order book. These indicators provide greater visibility over future performance …

Ankur Sharma | 26 August 2026
Support

Hi! How can we help you today?

Loading…